Position in ARGX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$301,525
+$62,734 QoQ
Shares Held
325
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#351
of 504 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STEPHENS INC /AR/ holds $5,456,488 across 11 Biotechnology names. ARGX ranks #8 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,900 | $1,440,517 | |
| 2 | TECH |
BIO-TECHNE Corp
|
12,036 | $850,343 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
831 | $518,161 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
1,625 | $513,646 | |
| 5 | EXEL |
Exelixis, Inc.
|
9,079 | $493,988 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,638 | $493,087 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
4,954 | $387,749 | |
| 8 | ARGX |
Argenx SE
This page
|
325 | $301,525 |
All Filings in ARGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,525 | 325 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $238,791 | 327 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $421,315 | 501 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $418,934 | 568 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $348,922 | 633 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $305,994 | 517 | Shares | Defined | 2025-05-01 | |
| 2024-12-31 | $309,960 | 504 | Shares | Defined | 2025-01-28 | |
| No filing history on record for this holder in this stock. | ||||||